IL6 and breast cancer: In the microenvironment of breast cancer, the expression and secretory spectrum of inflammatory mediators of adipocytes are changed, and the secretion of chemokines CCL5 and CCL2 and the inflammatory factors IL-6 and TNF-α are increased, which further promotes the proliferation and invasion of tumor cells and the formation of neovascularization.